(Q34661134)

3 August 2017

1 reference

title

Emerging pharmacotherapies for smoking cessation (English)

1 reference

3 August 2017

0 references

Candice L Garwood

1

1 reference

3 August 2017

Lisa A Potts

series ordinal

2

1 reference

3 August 2017

publication date

1 August 2007

1 reference

American Journal of Health-System Pharmacy

3 August 2017

published in

1 reference

3 August 2017

volume

64

1 reference

3 August 2017

issue

16

1 reference

3 August 2017

page(s)

1693-1698

1 reference

Cramér-Rao bounds for three-point decomposition of water and fat.

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060427

What to do with a patient who smokes

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060427

Current pharmacological treatments for nicotine dependence

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060427

Sensitization of the mesoaccumbens dopamine response to nicotine.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060427

Varenicline: the newest agent for smoking cessation

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060427

Expanding treatment of tobacco dependence

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060427

Repeated administration of the GABAB receptor agonist CGP44532 decreased nicotine self-administration, and acute administration decreased cue-induced reinstatement of nicotine-seeking in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060427

Rimonabant--a selective CB1 antagonist

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060427

Neuropharmacology and potential efficacy of new treatments for tobacco dependence

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060427

Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060427

Advances in pharmacotherapy for tobacco dependence.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060427

Non-nicotinic neuropharmacological strategies for nicotine dependence: beyond bupropion

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060427

SR141716, a central cannabinoid (CB(1)) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060427

Nicotine-associated cues maintain nicotine-seeking behavior in rats several weeks after nicotine withdrawal: reversal by the cannabinoid (CB1) receptor antagonist, rimonabant (SR141716).

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060427

Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060427

Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060427

A vaccine for nicotine dependence: targeting the drug rather than the brain

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060427

Effects of a nicotine conjugate vaccine on the acquisition and maintenance of nicotine self-administration in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060427

Active immunization against nicotine suppresses nicotine-induced dopamine release in the rat nucleus accumbens shell

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060427

A therapeutic vaccine for nicotine dependence: preclinical efficacy, and Phase I safety and immunogenicity

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060427

Maternal vaccination against nicotine reduces nicotine distribution to fetal brain in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060427

Vaccination against nicotine during continued nicotine administration in rats: immunogenicity of the vaccine and effects on nicotine distribution to brain

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060427

Trial watch: Xenova's TA-NIC vaccine shows promise

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060427

Safety and immunogenicity of a nicotine conjugate vaccine in current smokers

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060427

Nicotine delivery systems

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060427

Tolerability and pharmacokinetics of single and repeated doses of nicotine with The Straw, a novel nicotine replacement product

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060427

31 March 2020

Identifiers

DOI

10.2146/AJHP060427

1 reference

3 August 2017

1 reference